Telo Genomics Corp.
TDSGF
$0.07
$0.0057.69%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.01% | 28.52% | 19.17% | 31.19% | 14.48% |
| Total Depreciation and Amortization | -72.60% | -70.51% | -48.05% | -15.79% | 8.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,170.27% | -- | -- | -190.32% | -123.57% |
| Change in Net Operating Assets | -1,538.12% | 150.43% | 211.85% | -6.67% | 552.50% |
| Cash from Operations | -60.83% | 42.23% | 33.40% | 26.34% | 12.21% |
| Capital Expenditure | -- | -- | -- | -112.50% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -112.50% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -77.06% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 91.30% | 81.59% | -- |
| Cash from Financing | 98.20% | -- | 94.12% | -77.07% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.42% | 373.36% | 33.87% | -94.70% | 12.50% |